Susquehanna International Group
ICPT

Susquehanna International Group’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Susquehanna International Group’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-169,000
Closed -$3.13M – 13682
2023
Q3 		$3.13M Sell
169,000
-46,000
-21% -$520K ﹤0.01% 4300
2023
Q2 		$2.38M Sell
215,000
-20,600
-9% -$287K ﹤0.01% 4798
2023
Q1 		$3.16M Sell
235,600
-77,600
-25% -$1.34M ﹤0.01% 4219
2022
Q4 		$3.87M Sell
313,200
-276,500
-47% -$3.92M ﹤0.01% 3623
2022
Q3 		$8.23M Sell
589,700
-147,200
-20% -$2.37M ﹤0.01% 2438
2022
Q2 		$10.2M Buy
736,900
+461,600
+168% +$7.39M ﹤0.01% 2180
2022
Q1 		$4.48M Buy
275,300
+40,400
+17% +$633K ﹤0.01% 3823
2021
Q4 		$3.83M Buy
234,900
+126,000
+116% +$2.12M ﹤0.01% 4210
2021
Q3 		$1.62M Hold
108,900
– – ﹤0.01% 6297
2021
Q2 		$2.17M Buy
108,900
+15,000
+16% +$297K ﹤0.01% 5723
2021
Q1 		$2.17M Sell
93,900
-81,900
-47% -$2.28M ﹤0.01% 5729
2020
Q4 		$4.34M Buy
175,800
+63,200
+56% +$2.09M ﹤0.01% 3655
2020
Q3 		$4.67M Buy
112,600
+39,000
+53% +$1.79M ﹤0.01% 3140
2020
Q2 		$3.53M Sell
73,600
-45,500
-38% -$3.51M ﹤0.01% 3524
2020
Q1 		$7.5M Sell
119,100
-226,200
-66% -$20.3M ﹤0.01% 2083
2019
Q4 		$42.8M Buy
345,300
+64,800
+23% +$5.8M 0.01% 911
2019
Q3 		$18.6M Sell
280,500
-68,400
-20% -$4.59M 0.01% 1391
2019
Q2 		$27.8M Sell
348,900
-367,300
-51% -$32.9M 0.01% 1064
2019
Q1 		$80.1M Buy
716,200
+305,800
+75% +$33.4M 0.03% 440
2018
Q4 		$41.4M Buy
410,400
+41,300
+11% +$4.28M 0.02% 678
2018
Q3 		$46.6M Buy
369,100
+71,900
+24% +$7.61M 0.02% 747
2018
Q2 		$24.9M Buy
297,200
+9,800
+3% +$718K 0.01% 1124
2018
Q1 		$17.7M Sell
287,400
-161,600
-36% -$9.74M 0.01% 1306
2017
Q4 		$26.2M Sell
449,000
-321,800
-42% -$20.3M 0.01% 1065
2017
Q3 		$44.7M Buy
770,800
+589,800
+326% +$63.5M 0.02% 693
2017
Q2 		$21.9M Sell
181,000
-44,600
-20% -$5.17M 0.01% 1101
2017
Q1 		$25.5M Sell
225,600
-159,500
-41% -$18.6M 0.01% 913
2016
Q4 		$41.8M Sell
385,100
-34,800
-8% -$4.15M 0.02% 629
2016
Q3 		$69.1M Sell
419,900
-14,700
-3% -$2.32M 0.03% 420
2016
Q2 		$62M Buy
434,600
+88,000
+25% +$12.8M 0.03% 440
2016
Q1 		$44.5M Sell
346,600
-7,100
-2% -$838K 0.02% 571
2015
Q4 		$52.8M Buy
353,700
+25,500
+8% +$4.32M 0.02% 574
2015
Q3 		$54.4M Sell
328,200
-74,200
-18% -$16.3M 0.02% 593
2015
Q2 		$97.1M Sell
402,400
-31,700
-7% -$8.44M 0.04% 412
2015
Q1 		$122M Buy
434,100
+244,400
+129% +$52.9M 0.06% 307
2014
Q4 		$29.6M Sell
189,700
-93,700
-33% -$17.3M 0.01% 1038
2014
Q3 		$67.1M Buy
283,400
+10,600
+4% +$2.7M 0.03% 589
2014
Q2 		$64.6M Buy
+272,800
New +$71.9M 0.03% 566

Susquehanna International Group's ICPT Position: Q4 2023 in Review

Susquehanna International Group sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 366,014 shares — an estimated $6.79M sold.

Susquehanna International Group first reported a position in ICPT in Q3 2013 and held it in 40 quarters. The position peaked at $74.9M in Q3 2014. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

  • Susquehanna International Group reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
  • Susquehanna International Group sold 366,014 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $6.79M.
  • Susquehanna International Group first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2013 and held it in 40 quarters.
  • Susquehanna International Group's Intercept Pharmaceuticals, Inc. position peaked at $74.9M in Q3 2014.
  • 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.